Showing results (401-410 of 426) with videos related to
Sort By:
Pageof 43
American Heart Journal|February 26, 2008
Rationale and design of the Home Automatic External Defibrillator Trial (HAT)Gust H Bardy, Kerry L Lee, Daniel B Mark, et al.Nature Chemical Biology|February 6, 2023
Programmable synthetic biomolecular condensates for cellular controlYifan Dai, Mina Farag, Dongheon Lee, et al.Circulation|May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyMichael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.JACC. Heart Failure|December 21, 2023
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection FractionMichael A Fuery, Eric S Leifer, Marc D Samsky, et al.The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.European Journal of Heart Failure|May 16, 2018
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetesAbhinav Sharma, Sana M Al-Khatib, Justin A Ezekowitz, et al.The New England Journal of Medicine|November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndromeBradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.Nature Chemistry|February 10, 2025
Synthetic biomolecular condensates enhance translation from a target mRNA in living cellsDaniel Mark Shapiro, Sonal Deshpande, Seyed Ali Eghtesadi, et al.The New England Journal of Medicine|June 21, 2008
Rhythm control versus rate control for atrial fibrillation and heart failureDenis Roy, Mario Talajic, Stanley Nattel, et al.Circulation|June 4, 2024
Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart AssociationDhruv S Kazi, Mitchell S V Elkind, Anne Deutsch, et al.Pageof 43